Company Filing History:
1 out of 2 
1 out of 832,761 Years Active: 2014
Title: The Innovative Contributions of Do-Un Kim in Inflammatory Disease Treatment
Introduction
Do-Un Kim, an accomplished inventor from Gyeonggi-do, South Korea, has made significant strides in the field of medicinal chemistry, particularly in the treatment of inflammatory diseases. With one registered patent under his name, Kim's work focuses on the therapeutic potential of lignan compounds, demonstrating a commitment to innovative solutions in healthcare.
Latest Patents
Do-Un Kim holds a patent titled "Use of Lignan Compounds for Treating or Preventing Inflammatory Disease." This invention details a method for preventing or treating inflammatory conditions by administering an effective amount of macelignan, represented by a specific chemical formula or its pharmaceutically acceptable salts. This patent illustrates how lignan compounds can inhibit various inflammatory mediators such as NO, iNOS, PGE, COX-2, and TNF-α, showcasing their effectiveness in managing inflammatory diseases in vivo.
Career Highlights
Throughout his career, Do-Un Kim has been associated with notable organizations, including Newtree Industry Co., Ltd. His professional journey reflects an active engagement in research and development, with a clear focus on innovations that address health challenges.
Collaborations
Among the talented individuals in his professional network, Kim has collaborated with colleagues such as Jae-Kwan Hwang and Jae-Youn Chung. These collaborations highlight the importance of teamwork in advancing research and the development of effective treatment modalities.
Conclusion
Do-Un Kim's contributions to the field of inflammatory disease treatment underscore the potential of lignan compounds in medicinal applications. With his innovative approach and dedication to research, Kim continues to make impactful advancements, paving the way for future discoveries in healthcare. The work of inventors like him is crucial in the ongoing quest to find effective solutions for inflammatory conditions, ultimately benefiting patients worldwide.